Portage Biotech Inc (PRTG) — Capital Reinvestment Ratio

Latest as of June 2013: 0.02x

Portage Biotech Inc (PRTG) has a Capital Reinvestment Ratio of 0.02x as of June 2013, meaning it reinvests 0% of its operating cash flow ($217.91K) in capital expenditures ($5.30K). See PRTG equity financing ratio to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.02x

Capex / Operating Cash Flow

Operating Cash Flow

$217.91K

USD

Capital Expenditures

$5.30K

USD

Data as of

Jun 2013

Most recent filing

Annual Capital Reinvestment Ratio for Portage Biotech Inc (None–None)

Year-by-year Capital Reinvestment Ratio for Portage Biotech Inc from None to None. For live market cap and broader valuation context, see Portage Biotech Inc (PRTG) total market value.

Year	Reinvestment Ratio	Operating CF (USD)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow